These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19807240)

  • 21. Oral transmucosal fentanyl citrate--OTFC (ACTIQ) #103.
    Gordon D; Schroeder M
    J Palliat Med; 2008 May; 11(4):633-4. PubMed ID: 18454617
    [No Abstract]   [Full Text] [Related]  

  • 22. Fentanyl buccal tablet: rapid relief from breakthrough pain.
    Taylor DR
    Expert Opin Pharmacother; 2007 Dec; 8(17):3043-51. PubMed ID: 18001263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of breakthrough cancer pain].
    Sláma O
    Klin Onkol; 2013; 26(3):191-4. PubMed ID: 23763322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating cancer-related breakthrough pain: the oral transmucosal route.
    Laverty D
    Int J Palliat Nurs; 2007 Jul; 13(7):326-31. PubMed ID: 17851376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
    Slatkin NE; Xie F; Messina J; Segal TJ
    J Support Oncol; 2007; 5(7):327-34. PubMed ID: 17708123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fast-acting fentanyl preparations and pain management.
    McWilliams K; Fallon M
    QJM; 2013 Oct; 106(10):887-90. PubMed ID: 23613597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fentanyl transdermal system. Pain management at home.
    Woodroffe MA; Hays H
    Can Fam Physician; 1997 Feb; 43():268-72. PubMed ID: 9040914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Economic evaluation of fentanyl.
    Oster G
    J Pain Symptom Manage; 2001 Jul; 22(1):540-3. PubMed ID: 11523517
    [No Abstract]   [Full Text] [Related]  

  • 29. [Opioid induction using rapid release drugs and the shift to fentanyl patches].
    Sasaki S; Morohashi T; Otsuka Y; Ejima M; Tsujikawa Y; Yoshimura K; Terai E; Suzuki N; Nakayama H; Watanabe T
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):863-7. PubMed ID: 25131873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological and clinical differences among transmucosal fentanyl formulations for the treatment of breakthrough cancer pain: a review article.
    Corli O; Roberto A
    Minerva Anestesiol; 2014 Oct; 80(10):1123-34. PubMed ID: 24346227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain.
    Zeppetella G
    Palliat Med; 2000 Jan; 14(1):57-8. PubMed ID: 10717724
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Economic evaluation of the fentanyl transdermal system.
    Dukes EM; Dhanda R
    J Pain Symptom Manage; 2001 Jul; 22(1):538-40; author reply 541-3. PubMed ID: 11523516
    [No Abstract]   [Full Text] [Related]  

  • 33. [Three-day-type transdermal fentanyl patch conversion by rapid titration method with short-acting oral oxycodone for cancer pain].
    Yamazaki K; Fujio N; Ishikawa N; Watanabe H; Kameyama M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):405-8. PubMed ID: 22421768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are there cost benefits to fentanyl for breakthrough pain?
    Davis MP
    J Pain Symptom Manage; 2012 Sep; 44(3):e1-2. PubMed ID: 22939453
    [No Abstract]   [Full Text] [Related]  

  • 35. Consistent and clinically relevant effects with fentanyl buccal tablet in the treatment of patients receiving maintenance opioid therapy and experiencing cancer-related breakthrough pain.
    Zeppetella G; Messina J; Xie F; Slatkin NE
    Pain Pract; 2010; 10(4):287-93. PubMed ID: 20230447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternatives to oral opioids for cancer pain.
    Mercadante S; Fulfaro F
    Oncology (Williston Park); 1999 Feb; 13(2):215-20, 225; discussion 226-9. PubMed ID: 10079471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Breakthrough pain--analysis and therapy. A pilot study of a new drug, transmucosal fentanyl (Actiq)].
    Johansson H; Arnér S
    Lakartidningen; 2004 Feb; 101(7):552-4. PubMed ID: 15024861
    [No Abstract]   [Full Text] [Related]  

  • 38. Transdermal fentanyl: new preparation. An alternative to morphine.
    Prescrire Int; 1998 Oct; 7(37):137-40. PubMed ID: 10915416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transdermal fentanyl].
    Lossignol D; Sternon J
    Rev Med Brux; 1998 Apr; 19(2):83-6. PubMed ID: 9643088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies.
    Davies A; Zeppetella G; Andersen S; Damkier A; Vejlgaard T; Nauck F; Radbruch L; Sjolund KF; Stenberg M; Buchanan A
    Eur J Pain; 2011 Aug; 15(7):756-63. PubMed ID: 21251860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.